
The pharmaceutical industry is well-positioned for growth, given its robust demand, increasing healthcare spending and rising global elderly population. So, investors could consider adding quality pharma stocks Dr. Reddy’s Laboratories Limited (RDY), Novo Nordisk A/S (NVO), and AbbVie Inc. (ABBV) to one’s portfolio this month.
The pharmaceutical market is experiencing robust growth driven by innovative drugs and increasing healthcare demand, especially in emerging nations. This year, the global pharmaceutical market is poised to achieve revenues of $1.12 trillion. Looking to the future, the global pharmaceutical market is expected to reach $1.48 trillion by 2028, exhibiting a CAGR of 5.8%.